PLIN1: A Drug Target / Disease Biomarker (G5346)

Target Name: PLIN1

NCBI ID: G5346

PLIN1

PLIN1: A Drug Target / Disease Biomarker

PLIN1, also known as P1-AS-3, is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the P1 family of transmembrane proteins, which are characterized by the presence of a single transmembrane protein that is involved in various cellular processes.

One of the key functions of PLIN1 is its role in the regulation of cell signaling pathways. Specifically, PLIN1 has been shown to play a role in the regulation of the Wnt signaling pathway, which is a critical pathway involved in the development and maintenance of tissues in the body.

Wnt signaling is a signaling pathway that is involved in the regulation of cell proliferation, differentiation, and survival. It is a highly conserved pathway that is found in many different organisms, including humans.

In humans, the Wnt signaling pathway is involved in the development and maintenance of various tissues, including the nervous system, endoderm, mesoderm, and epithelial tissues. It is also involved in the regulation of various cellular processes, including cell signaling, cell adhesion, and cell migration.

PLIN1 has been shown to play a key role in the regulation of Wnt signaling pathway. It is a negative regulator of the Wnt signaling pathway, which means that it works to inhibit the activity of proteins that are involved in the pathway.

Specifically, PLIN1 has been shown to interact with the protein SMAD, which is a key regulator of the Wnt signaling pathway. This interaction between PLIN1 and SMAD allows PLIN1 to inhibit the activity of SMAD, which in turn regulates the activity of the Wnt signaling pathway.

PLIN1 has also been shown to interact with the protein FGF, which is another key regulator of the Wnt signaling pathway. This interaction between PLIN1 and FGF allows PLIN1 to regulate the activity of FGF, which is involved in the development and maintenance of tissues in the body.

In addition to its role in the regulation of the Wnt signaling pathway, PLIN1 has also been shown to play a role in the regulation of other cellular processes. For example, it is involved in the regulation of cell signaling, cell adhesion, and cell migration, and has been shown to play a key role in the development and maintenance of various tissues in the body.

PLIN1 is also a potential drug target for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Its role in the regulation of the Wnt signaling pathway makes it an attractive target for drugs that are designed to inhibit the activity of pathway-regulated proteins.

In conclusion, PLIN1 is a protein that is expressed in various tissues of the body and plays a critical role in the regulation of cell signaling pathways, including the Wnt signaling pathway. Its potential as a drug target makes it an attractive target for the development of new treatments for a variety of diseases.

Protein Name: Perilipin 1

Functions: Modulator of adipocyte lipid metabolism. Coats lipid storage droplets to protect them from breakdown by hormone-sensitive lipase (HSL). Its absence may result in leanness. Plays a role in unilocular lipid droplet formation by activating CIDEC. Their interaction promotes lipid droplet enlargement and directional net neutral lipid transfer. May modulate lipolysis and triglyceride levels

The "PLIN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLIN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets